ArticleCureus2025
Prevalence and Associated Factors of Hypoglycemia Among Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with type 2 diabetes mellitus (T2DM) often experience hypoglycemia, an underappreciated consequence that has a major negative influence on treatment compliance and quality of life.
objectiveThis study aimed to determine the prevalence and associated factors of hypoglycemia among patients with T2DM, with a focus on treatment types, comorbidities, and glycemic control. By providing population-specific data, the study intends to inform clinical decision-making and contribute to safer, more personalized diabetes management strategies. METHODOLOGY: This cross-sectional observational multicenter study was conducted from April 2023 to March 2024. There were 364 T2DM patients in all. Structured interviews were used to gather data, which included pertinent clinical indicators, treatment plans, self-reported hypoglycemia episodes, and demographics. Symptoms or verified blood glucose levels below 70 mg/dL were used to define hypoglycemia. SPSS version 26 (IBM Corp., Armonk, NY, US) was used for statistical analysis.
resultsHypoglycemia was present in 112 patients (30.77%) overall, with 59 patients (16.20%) reporting frequent episodes and eight patients (2.19%) reporting extremely frequent occurrences. The most frequently reported symptoms were shakiness in 64 patients (17.54%), dizziness in 56 patients (15.37%), and sweating in 52 patients (14.29%). Hypoglycemia was most common among 152 patients (41.75%), followed by 98 sulfonylurea users (26.92%), and 69 metformin users (18.95%). It was more prevalent in patients with glycated hemoglobin (HbA1c) > 7.5%: 159 patients (43.68%).
conclusionPatients with type 2 diabetes often experience hypoglycemia, which is more common in individuals with higher HbA1c levels and is particularly common in those on insulin and sulfonylureas. To reduce the risk of hypoglycemia, careful glycemic control management is necessary.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.